GLENMARK PHARMACEUTICALS LTD. - Glenmark Pharmaceuticals receives ANDA approval for Potassium Chloride Extended-Release Capsules USP, 10 mEq
21 Jan 2016
Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated January 21, 2016 titled "Glenmark Pharmaceuticals receives ANDA approval for Potassium Chloride Extended-Release Capsules USP, 10 mEq".
Source:
BSE India